THIRD AMENDMENT TO RESEARCH AND LICENCE AGREEMENTResearch and Licence Agreement • July 25th, 2018 • Cell Source, Inc. • Pharmaceutical preparations
WHEREAS Yeda and Cell Source are parties to a research and licence agreement dated October 3, 2011, as amended by a first amendment thereto dated April 8, 2014 and a second amendment dated November 28, 2016 ("the R&L Agreement”); and
FOURTH AMENDMENT TO RESEARCH AND LICENCE AGREEMENT (this “Amendment”)Research and Licence Agreement • July 25th, 2018 • Cell Source, Inc. • Pharmaceutical preparations
WHEREAS Yeda and Cell Source are parties (the “Parties”) to a research and licence agreement dated October 3, 2011, as amended by a first amendment thereto dated April 8, 2014 a second amendment thereto dated November 28, 2016, and a third amendment dated March 29, 2018 (together, "the R&L Agreement”); and
SECOND AMENDMENT TO RESEARCH AND LICENCE AGREEMENT (this “Amendment”)Research and Licence Agreement • July 25th, 2018 • Cell Source, Inc. • Pharmaceutical preparations
WHEREAS Yeda and Cell Source are parties to a research and licence agreement dated October 3rd, 2011, as amended by a first amendment thereto dated April 8, 2014 (together, "the R&L Agreement”); and
